This cross-sectional study was conducted to determine the incidence of autoantibodies to phospholipids and coagulation proteins in children with acute varicella zoster virus (VZV) infection. Study groups included children with VZV alone or complicated by purpura fulminans and/or thromboembolism. VZV naïve children and children who had VZV Ͼ1 y before sample collection formed a control group. Blood was assayed for the following: free protein S (PS), protein C, antithrombin, and prothrombin; antibody binding to these proteins; lupus anticoagulant; anticardiolipin antibody; antiphospholipid antibodies; and prothrombin fragment 1ϩ2. Data regarding coinfections was collected. Forty-three VZV-infected children showed an increased frequency of lupus anticoagulant, anticardiolipin antibody, antiphospholipid antibodies, and autoantibodies to PS, protein C, prothrombin, and antithrombin in comparison to 52 children without acute VZV (p Ͻ 0.0001). Seventeen children with VZV and purpura fulminans and/or thromboembolism showed a statistically significant decrease in free PS, significantly increased PS IgG antibody, and significantly increased prothrombin fragment 1ϩ2 (p Ͻ 0.0001) compared with the group without acute VZV and the group with uncomplicated VZV. Twenty-six children with uncomplicated VZV showed In a 1990 review, Francis (1) reported the association of VZV and/or streptococcal infection in 30% of children with idiopathic purpura fulminans. Subsequently, acquired free PS deficiency was described in children and adults with acute VZV infection and PFϮTE (2-8). We reported the LA and free PS deficiency in seven previously healthy children with acute VZV infection complicated by PFϮTE (6). We previously found evidence suggestive of an autoimmune cause of acquired PS deficiency.
In a 1990 review, Francis (1) reported the association of VZV and/or streptococcal infection in 30% of children with idiopathic purpura fulminans. Subsequently, acquired free PS deficiency was described in children and adults with acute VZV infection and PFϮTE (2) (3) (4) (5) (6) (7) (8) . We reported the LA and free PS deficiency in seven previously healthy children with acute VZV infection complicated by PFϮTE (6) . We previously found evidence suggestive of an autoimmune cause of acquired PS deficiency.
We now report a cross-sectional study designed to determine the prevalence of autoantibodies directed against a variety of phospholipids and coagulation proteins in previously healthy children with VZV infection. The aim of this study was to compare results obtained on blood samples from children with uncomplicated acute VZV infection with samples from children with acute VZV complicated by symptomatic PFϮTE. It was hypothesized that coagulation abnormalities in the children with symptomatic PFϮTE would be more prevalent and more severe but not intrinsically different from those found in healthy children with uncomplicated VZV infection.
METHODS

Clinical Methods
This cross-sectional study was performed with the approval of the Colorado Multi-Institutional Review Board and the Pediatric Clinical Research Center at The Children's Hospital of Denver. Informed consent and assent forms were signed before enrollment in the study.
Three study groups of children were identified and recruited concurrently. Group 1 was composed of children who had no history of VZV infection or had VZV Ͼ1 y before sample collection, no personal or family history of bleeding or thrombotic disorders, and no evidence of infection or antibiotic use for at least 4 wk before blood sampling. Group 2 included children with acute uncomplicated VZV infection and no personal or family history of bleeding or thrombotic disorders. Group 3 was composed of children with acute VZV infection complicated by PFϮTE.
Children were recruited at Pediatric Resident Continuity Clinics at Denver Health Medical Center, The Children's Hospital of Denver, from staff members at The University of Colorado Health Sciences Center, or by referral to one of the authors. The diagnosis of VZV was made on visual inspection of typical skin lesions and confirmed with IgG serology. The diagnosis of purpura fulminans was made clinically and included typical palpable, indurated skin lesions of the trunk and extremities progressing from dark red to black and resulting in skin necrosis. All diagnoses of purpura fulminans were made in the pediatric intensive care unit of The Children's Hospital of Denver. All diagnoses of thromboembolism were confirmed with high-resolution real-time and Doppler ultrasonography, magnetic resonance angiography, or pulmonary ventilation/ perfusion scanning as appropriate. The diagnosis of Streptococcus was made on the basis of the result of clinically ordered blood or skin cultures.
Children between the ages of 3 mo and 18 y were eligible for the study. Nine milliliters of blood drawn into 1 mL of 3.8% sodium citrate and 5 mL of whole blood were collected from each subject. Citrated samples were immediately placed on ice and centrifuged twice at 1800 ϫ g for 20 min at 4°C. Whole blood samples were allowed to clot at 37°C for 1 h before separating serum. Aliquots of plasma and serum were frozen at Ϫ70°C until the time of assay.
Three children whose samples were included in group 1 subsequently developed VZV infection. They and their parents agreed to additional blood sampling at the time of acute uncomplicated VZV infection and 3 mo after VZV infection. Blood samples drawn at the time of acute uncomplicated VZV from these three children were included in group 2.
Laboratory Methods
Plasma concentration of the vitamin K-dependent anticoagulant PS was determined for the study groups. For comparison, F II was chosen as a vitamin K-dependent procoagulant protein, PC as a vitamin K-dependent anticoagulant protein, and AT as a vitamin K-independent anticoagulant protein. To determine whether there is an autoimmune basis for protein deficiencies, ELISA assays were performed to detect plasma IgG and IgM antibodies binding to PS, PC, F II, and AT. To determine whether an individual had a hypercoagulable state, plasma concentrations of the prothrombin activation fragment, F 1ϩ2, were assayed.
Purified antigens used to determine antibody specificity. Varicella antigens were purchased from BioWhittaker (Walkersville, MD, U.S.A.). PS, PC, AT, and F II were obtained from Enzyme Research (South Bend, IN, U.S.A.). Fibrinogen was purchased from Kabi Vitrum (Stockholm, Sweden).
Antibody to VZV. An IgG antibody response to VZV was determined using an ELISA assay (VZV STAT, BioWhittaker).
Lupus anticoagulant. The LA was deemed present if there was prolongation of the activated partial thromboplastin time (APTT) or dilute Russell viper venom time that did not correct with the addition of 1:1 standard normal plasma and corrected with addition of platelet phospholipid in accordance with the criteria of the Lupus Anticoagulant Subcommittee of the International Society for Thrombosis and Haemostasis (9) .
Anticardiolipin antibody. IgG and IgM antibodies to cardiolipin were determined in ELISA assays (Inova, San Diego, CA, U.S.A.) (10) .
Antiphospholipid antibody. IgG and IgM antibodies in a mixture of cardiolipin, phosphatidic acid, and phosphatidylserine were semiquantitatively measured in an ELISA assay containing ␤ 2 -glycoprotein I (Asserachrom APA, American Bioproducts, Parsippany, NJ, U.S.A.). In this manuscript, APA will represent this specific ELISA test and not the more general term, antiphospholipid antibody.
Plasma concentrations of coagulation proteins. Free PS antigen concentrations were determined in an ELISA assay (Asserachrom Free Protein S, Diagnostic Stago, France). For this study we chose to assay free PS, or the compartment of PS not bound to circulating C 4 b-binding protein, because the free compartment of PS contributes anticoagulant function and because free PS deficiency was found to be most severe in the seven originally published patients with VZV-induced PS deficiency. PC activity was quantified in a chromogenic assay (Coamatic Protein C, Chromogenix, Milan, Italy). F II activity was determined in a standard one-stage clotting assay. AT activity was assessed in an amidolytic assay (Coamatic Antithrombin III, Chromogenix).
Prothrombin fragment 1؉2. Plasma concentrations of the prothrombin activation fragment, F 1ϩ2, were determined using an ELISA assay (Ezygnost F 1ϩ2, Behring Diagnostics Inc., Westwood, MA, U.S.A.).
Plasma concentrations of IgG and IgM antibodies to coagulation proteins. Binding of patient plasma IgG or IgM to coagulation proteins was determined in ELISA assays. One hundred microliters of purified capture antigen diluted in carbonate buffer was applied to a 96-well ELISA plate (Nunc Maxisorb substrate kit (contains peroxidase solution and 3, 3Ј, 5, 5Ј tetramethylbenzidine, Pierce Chemical Co., Rockford, IL, U.S.A.) and incubated for 2 h at 20°C. The plates were washed three times after application of capture antigen using a PBS containing BSA and Tween 20. The plates were then blocked three times with Superblock (Pierce Chemical Co., Rockford, IL, U.S.A.). One hundred microliters of patient plasma, diluted 1:500 -1:40,000 in Superblock plus 0.05% Tween 20, was applied and incubated for 2 h at 20°C. After application of plasma, plates were again washed three times. One hundred microliters of horseradish peroxidase-conjugated goat antihuman IgG or IgM Fc-specific antibody was applied and incubated at room temperature for 1 h. Finally, the sample was washed three times, and the color was developed with TMB, Nalge Nunc International, Rochester, NY, U.S.A. OD was 346 determined. Concentrations of purified antigens included PS, 2.5 g/mL; PC, 1.0 g/mL; F II, 1.2 g/mL; or AT, 0.15 g/mL.
Because the ELISA assays use diluted patient plasma, it is possible that antibody reactions detected were against complexes of coagulation proteins with phospholipids. To control for this possibility, IgG antibodies were isolated using barium chloride precipitation and absorption with protein A Sepharose. Antibodies with specificity to varicella or VZV antigens were further purified by affinity chromatography using a commercial medium (3M Emphaze Biosupport medium, Pierce Chemical Co) that immobilized purified PS or VZV antigens.
Statistical Methods
ANOVA was used to test for differences in means among all three groups. When ANOVA showed statistically significant results, a t test was used to compare means between two groups 
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VARICELLA-AUTOANTIBODY SYNDROME at a time. This is not the most conservative approach, because it does not preserve the 0.05 level of significance. However, we chose this method to detect any real difference between two groups. Fisher's exact test was used to test for differences in proportions among all three groups, because several of the comparisons had expected cell sizes that were fewer than five. When the Fisher's exact test showed statistically significant results, Fisher's exact test was also used to compare proportions between pairs of groups.
Contingency coefficients were calculated to determine relationships between dichotomous variables that were not normally distributed. The associated p value for the 2 was used to test statistical significance of the coefficients. Regression analysis was used to estimate the relationship between a dependent and an independent variable.
RESULTS
Clinical Results
Blood samples drawn from 95 children were studied. The samples were collected from March 1992 through October 1997. This study population includes the previously reported children with acute varicella infection (6) .
Fifty-two children without acute VZV (group 1) had a mean age of 8.0 y (range, 3 wk-17 y). Eighteen of these children were seronegative for VZV antibodies, and 34 children were seropositive with a history of clinical varicella Ն1 y before sample collection. Sixty-three percent were female; 63% were white, 12% were Hispanic, 23% were African-American, and race/ethnicity was unknown for 2%.
Twenty-six children had serologically confirmed acute uncomplicated VZV infection (group 2); they had a mean age of 5.5 y (range, 1-11 y). Fifty-four percent were female; 58% were white, 19% were Hispanic, and 23% were AfricanAmerican. Blood sample collection was performed a mean of 14.2 d after first chicken pox identification.
Seventeen children had serologically confirmed acute VZV complicated by PFϮTE (group 3). This group had a mean age of 5.5 y (range, 5 mo -14 y). Fifty-three percent were female; 71% were white, 12% were Hispanic, 6% were AfricanAmerican, and 12% were Asian. Blood sample collection was performed a mean of 17.6 d after first chicken pox identification. Table 1 lists the clinical presentation and outcome of group 3 subjects. Eight children were coinfected with Streptococcus; six had purpura fulminans. An additional child had purpura fulminans, but was coinfected with Pseudomonas.
Laboratory Results
Control experiments regarding antibody specificity. Isolated IgG antibodies reacted in the ELISA assay similar to diluted plasma, excluding the possibility that these antibodies are against complexes of proteins with phospholipid. IgG further isolated by affinity to VZV did not show positivity to PC, AT, or phospholipids in ELISA assays but did show positivity with PS and F II. This suggests that there may be cross-reactivity between VZV antigens and autoantibodies to PS and F II, but not between VZV and other coagulation proteins or phospholipids.
Laboratory results in children. The proportions of children who showed evidence for autoantibodies including APA or specific coagulation protein antibodies are displayed in Figure  1 . All autoantibodies were significantly more prevalent in groups 2 and 3 as compared with group 1, with the exception of ACA in group 2 compared with group 1. The prevalence of Seventy-five percent of the children in groups 2 and 3 who were positive for either APA or coagulation protein antibodies were positive for both. When examined by group, 88% of group 3 children with one autoantibody type were positive for both whereas 46% of group 2 children with one autoantibody type were positive for both. Those proportions were significantly different (p ϭ 0.014). Results shown in Table 2 demonstrate highly significant correlations between autoantibodies.
The plasma concentration of free PS (Fig. 2) was significantly lower in group 3 compared with groups 1 or 2 and in group 2 versus group 1. PS IgG antibody levels (Fig. 3) were significantly elevated in group 3 compared with groups 1 and 2, and group 2 levels were significantly higher than those in group 1. Pooling results of all samples, there was a negative correlation between PS IgG antibody levels and free PS concentration (Fig. 4 , r ϭ Ϫ0.677; p Ͻ 0.0001). There were no significant correlations between IgG antibody binding and corresponding concentrations of PC, F II, and AT.
To estimate hypercoagulability, plasma concentrations of the F 1ϩ2 were determined (Fig. 5) . The results show elevations in group 3 children (p Ͻ 0.0001) compared with groups 1 and 2. Groups 1 and 2 were not significantly different. We hypothesized that hypercoagulability was related to PS autoantibodies. In addition, a positive correlation was found between PS IgG antibody levels and concentrations of F 1ϩ2 (Fig. 6 , r ϭ 0.579; p Ͻ 0.0001).
Results in group 3 children were compared relative to diagnosis of purpura fulminans (Table 3) . Group 3 children with PF did not differ from those without PF with respect to the following: age; activated partial thromboplastin time; Eight children in group 3 had clinical evidence of bacterial sepsis or superinfection of the varicella lesions. All eight clinically suspected infections were proven by culture to be GABHS. The mean levels of PS IgG antibody and F 1ϩ2 in these eight children were not statistically different from the other nine children in group 3 (p Ͼ 0.05). However, the mean PS concentration in the GABHS-infected children was significantly lower than the mean for the other group 3 children (p ϭ 0.036).
The three group 1 children who developed VZV infection after their initial samples were drawn underwent blood sampling during the acute and convalescent phases of infection as well. The mean pre-VZV values for these three children are as follows: PS, 98.0 U/dL; PS IgG, 0.023 OD; PC, 93.5 U/dL; PC IgG, 0.013 OD; F II, 96.5 U/dL; F II IgG, 0.00 OD; F 1ϩ2, 0.837 nM. An additional seven children from groups 2 and 3 had samples drawn during and Ն3 mo after acute VZV infection. Table 4 
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DISCUSSION
VZV is an early childhood viral infection that elicits a brisk immunologic response. Because of its unusually long incubation period (14 -21 d) , infected children are generally found to have IgG antibodies at the time of or shortly after presentation with skin lesions. IgG-mediated postinfectious autoimmune disorders, including immune thrombocytopenia purpura, can present in VZV-infected children (11) . We previously reported that some children with VZV infection complicated by PFϮTE had evidence of APA (6) . In addition, these children had PS antibodies. The PS antibodies were nonneutralizing and appeared to increase PS clearance from plasma. We speculated that these PS antibodies correlated with the thrombotic potential (2, 6) .
In this study of previously healthy children with VZV infection we found a significantly higher prevalence of APA and coagulation protein autoantibodies compared with children without acute VZV. In general, the presence of APA and coagulation protein antibodies was similar among all children with acute varicella, regardless of whether they had complications. Other studies have shown that the LA is more prevalent in children after infection (12, 13) . Although controversial, there are data relating postinfectious LAs to thrombosis (14 -18). In evaluating the groups to detect a marker that correlated with thrombosis, we found that children with VZV complicated by PFϮTE had significantly higher mean PS IgG antibody levels, significantly decreased mean PS levels, and significantly elevated mean F 1ϩ2 concentrations as compared with control children and those with uncomplicated varicella. These findings were independent of the diagnosis of PF. The pattern of immunologic response was the same in children with VZV infection with or without thrombotic complications, but the intensity of the antibody response was greater in children with PFϮTE.
Similar to VZV, infection with Streptococcus has previously been shown to induce a number of autoimmune diseases, including immune thrombocytopenia purpura, acute rheumatic fever, and Sydenham's chorea (19, 20) . VZV appears to increase susceptibility of children to streptococcal infection (21) . Both VZV and GABHS infect skin and endothelial cells. The physical trauma of this coinfection may have triggered thrombus initiation. Although our study was not designed to test the effect of GABHS on the immune system or clinical course in children with VZV, the observed high coinfection rate in group 3 remains interesting.
There are several possible explanations for the observed results. VZV may allow the presentation of the host antigens in a manner that causes an autoimmune response. This has been observed in a mouse model of autoimmune myocarditis after coxsackie infection (22, 23) . In that model, autoantibodies to cardiac myosin were related to presentation of cardiac myosin to T cells with very high expression of cytokines IL-1 and tumor necrosis factor. Alternatively, there could be epitope mimicry between the infecting virus and a host protein(s) causing an autoimmune response by cross-reactivity. This mechanism has also been described in a mouse model of viral myocarditis (24, 25) . Finally, VZV may stimulate a very robust but nonspecific immunologic response that includes antibodies against phospholipids and a spectrum of coagulation proteins.
We conclude that acute VZV infection predisposes children to a brisk but nonspecific immunologic response with multiple antiphospholipid and coagulation autoantibodies. A small number of children with autoantibodies associated with VZV have PFϮTE. These children appear to have a more specific autoimmune effect on PS, supporting the possibility that epitope mimicry, if involved, may be limited to VZV and PS cross-reactivity. In addition, GABHS may act as a trigger or cofactor in thrombus initiation. Further study of the molecular and immunologic mechanisms of the varicella-autoantibody syndrome is clearly warranted.
